1 | LLY | Eli Lilly and Company | 7.47% |
2 | ABT | Abbott Laboratories | 4.96% |
3 | LON: AZN | AstraZeneca PLC | 4.44% |
4 | RHHBY | Roche Holding AG | 4.19% |
5 | UNH | UnitedHealth Group Incorporated | 4.07% |
6 | GILD | Gilead Sciences, Inc. | 3.83% |
7 | MDT | Medtronic plc | 3.66% |
8 | BSX | Boston Scientific Corporation | 3.59% |
9 | ABBV | AbbVie Inc. | 3.58% |
10 | TMO | Thermo Fisher Scientific Inc. | 3.35% |
11 | CPH: NOVO.B | Novo Nordisk A/S | 3.33% |
12 | SWX: NOVN | Novartis AG | 3.29% |
13 | BBIO | BridgeBio Pharma, Inc. | 3.09% |
14 | VRTX | Vertex Pharmaceuticals Incorporated | 2.62% |
15 | AMGN | Amgen Inc. | 2.59% |
16 | MRK | Merck & Co., Inc. | 2.55% |
17 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.51% |
18 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.50% |
19 | DHR | Danaher Corporation | 2.41% |
20 | EW | Edwards Lifesciences Corporation | 2.22% |
21 | REGN | Regeneron Pharmaceuticals, Inc. | 2.16% |
22 | BMY | Bristol-Myers Squibb Company | 2.08% |
23 | DXCM | DexCom, Inc. | 2.00% |
24 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 1.94% |
25 | MCK | McKesson Corporation | 1.90% |
View HRTS holdings |